Vericel (VCEL) Selling, General & Administrative (2010 - 2026)
Vericel (VCEL) posted Selling, General & Administrative of $48.48 million for Q2 2026, up 15.7% from $41.91 million a year earlier but down 1.5% from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Vericel was $180.98 million, up 15.4% year-over-year; for FY2025, it came in at $166.99 million, up 16.9% from FY2024.
- Annual Selling, General & Administrative has increased for 12 consecutive years, with a five-year compound annual growth rate of 19.4% (FY2020 to FY2025).
- In prior years, Vericel's Selling, General & Administrative was $142.79 million in FY2024 (+18.0%), $121 million in FY2023 (+13.2%), $106.9 million in FY2022 (+9.5%) and $97.59 million in FY2021 (+41.8%).
- Quarterly Selling, General & Administrative has run from a low of $22.78 million in Q3 2021 to a high of $49.23 million in Q1 2026 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last 49 quarters, with growth averaging 17.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 3.6% (Q2 2022) to 42.4% (Q4 2021).
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $49.23 million (Q1 2026), $43.46 million (Q4 2025) and $39.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Vericel | 2.05 Bn | 1.47 Bn | 56.40 Mn | 48.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.48 Mn |
| Mar 31, 2026 | 49.23 Mn |
| Dec 31, 2025 | 43.46 Mn |
| Sep 30, 2025 | 39.82 Mn |
| Jun 30, 2025 | 41.91 Mn |
| Mar 31, 2025 | 41.80 Mn |
| Dec 31, 2024 | 35.10 Mn |
| Sep 30, 2024 | 38.03 Mn |
| Jun 30, 2024 | 35.27 Mn |
| Mar 31, 2024 | 34.40 Mn |
| Dec 31, 2023 | 30.88 Mn |
| Sep 30, 2023 | 29.99 Mn |
| Jun 30, 2023 | 30.65 Mn |
| Mar 31, 2023 | 29.49 Mn |
| Dec 31, 2022 | 26.92 Mn |
| Sep 30, 2022 | 26.98 Mn |
| Jun 30, 2022 | 27.14 Mn |
| Mar 31, 2022 | 25.87 Mn |
| Dec 31, 2021 | 25.97 Mn |
| Sep 30, 2021 | 22.78 Mn |
API Access
Vericel Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();